… Type 2 diabetes (T2D) is a metabolic disease characterized by defects in glycemia
regulation. This disease is associated with alterations in insulin action and lipid metabolism, …

… defined when body mass index was 23 kg/m 2 or higher; T2DM, type 2 diabetes mellites
according to the Korean Diabetes Association (KDA) T2DM was defined as fasting plasma …

… greater side effects … type II DM, the conventional treatment approaches (mono and combination
therapy) as well as the nano based drug delivery approaches for the treatment of type II …

… effects have been widely reported, they have the potential to be a great therapeutic agent for
type 2 diabetes with less side effects… to induce diabetes, hyperglycemia and hyperlipidemia …

… disease included hypertension and dyslipidemia, confirmed … 1.73 m 2 of body-surface area,
diabetic peripheral neuropathy … to have neutral effects 7 or potentially harmful side effects. …

… due endocrine disease drugs side effects [1, 2]. International … insulin resistance and
dyslipidemia in patients with type 2 diabetes [3]. The results of several studies comparing the effect of …

… of lipid profiles have some side effects including cataract, … Using substitute treatments
without the possible side-effects … dyslipidemia and improve glucose homeostasis in type 2 DM (…

… ), type 2 diabetes mellitus (T2DM), obesity, dyslipidemia, and … discontinued in patients with
diabetes and the medications … any negative effects of these agents in patients with diabetes …

… effect with moderate PPAR-γ effect. Saroglitazar is already approved in India since 2013 for
diabetic dyslipidemia … therapy to metformin for treatment of type 2 diabetes mellitus in India. It …

… a variety of side effects, including blood … Type 2 diabetes mellitus is a chronic metabolic
disease characterized by uncontrolled insulin secretion, hyperglycemia, and hyperlipidemia (1). …